Abilify (aripirazole) is an antipsychotic medication used to treat schizophrenia, bipolar disorder, major depressive disorder, Tourette syndrome, and irritability associated with autism. One of the top selling medications in the U.S. to treat mental disorders, it is now linked to uncontrollable urges to gamble, binge eat, shop and hyper-sexuality. These impulse control problems may result in harm to those taking the drug or others if the urges are left unrecognized and untreated.
Abilify is manufactured by Bristol-Myers Squibb and has been on the market since November of 2002. Aripiprazole is available under the brand names Abilify, Abilify Maintena, and Aristada. In May of 2016 the FDA issued a Safety Communication for Abilify requiring the label to be updated to include warnings regarding uncontrollable urges to gamble, eat, shop, and hyper-sexuality. The FDA has received at least 184 reports of impulse-control disorders since Abilify was approved in 2002.
At McDivitt Law Firm, we feel that you deserve information that may be relevant to your rights as a consumer. We want to alert you to a potential claim regarding this medication that you or someone you know may have been prescribed.
We may be able to help you if:
- You have taken Abilify, and
- You developed uncontrollable urges such as: compulsive gambling, shopping, overeating, or hypersexuality.
If you have been seriously affected by Abilify, please contact us for a free confidential evaluation.